[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Haberman et al., 1960 - Google Patents

The reliability of anti-human serums in the detection of ABO hemolytic disease of the newborn, by means of the direct antiglobulin test

Haberman et al., 1960

Document ID
10679451378522441319
Author
Haberman S
Aguilar E
Solomon J
Tripp J
Publication year
Publication venue
American Journal of Clinical Pathology

External Links

Snippet

MATERIALS AND METHODS For the present study, 3 lots of antiglobulin which met the present Minimum Requirements were obtained from 3 sources. A fourth serum had been previously tested and selected for its ability to detect adsorbed antibodies on the …
Continue reading at academic.oup.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/536—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Payne et al. Fetomaternal leukocyte incompatibility
Mayne et al. Rh immunization by the partial D antigen of category DVa
Svejgaard et al. Complement-fixing platelet iso-antibodies
Chan‐Shu et al. A new method of antibody elution from red blood cells
Haberman et al. The reliability of anti-human serums in the detection of ABO hemolytic disease of the newborn, by means of the direct antiglobulin test
Greenwalt et al. The Lutheran blood groups: a second example of anti-Lub and three further examples of anti-Lua
Madsen et al. A Korean family showing inheritance of A and B on the same chromosome
Bialek et al. Distribution and quantity of leukocyte antigens in the formed elements of the blood
Freiesleben et al. Haemolytic Disease of the Newborn Caused by Anti‐M: The Value of the Direct Conglutination Test
Arcilla et al. Le^ x, the Spurned Antigen of the Lewis Blood Group System
Haberman et al. ABO isoimmunization: the use of the specific Coombs and heat elution tests in the detection of hemolytic disease
Jones et al. Anomalous ABO grouping due to a new serum factor reactive with a reagent coloring material
YUNIS et al. Demonstration of isoantigenic receptors on human epidermal cells and established cell lines
Kipnis et al. Observations on an agglutinin in human serum for periodate-treated erythrocytes
Brody et al. Globulin coating of neoplastic lymphocytes in chronic lymphocytic leukemia
Triantaphyllopoulos et al. Complement in hemolytic disease of the newborn
Matsuda et al. Neonatal alloimmune thrombocytopenic purpura associated with sensitization against the platelet‐specific antigen Yuka
Solomon Comparison of fetal and adult ABH antigens by the quantitative hemagglutination technic
Denborough et al. Serum blood group substances and ABO haemolytic disease
O'Riordan et al. Potent anti‐s in pregnancy
Gralnick et al. Anti‐Lu 11: Another Antibody Defining a High‐Frequency Antigen Related to the Lutheran Blood Group System 1
Diamond The production and proper use of Rh typing reagents
Sturgeon et al. Anti‐γ‐Globulins in Women Treated with Anti‐Rh γ‐Globulin
Mohn et al. An Inherited Blood Group A Variant in the Finnish Population: I. Basic Characteristics 1
WHEELER et al. Determination of anti-Rh antibody in infants with erythroblastosis fetalis